Hill-Rom (HRC) 10-Q 2 May 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Mar. 31, 2014	Apr. 23, 2014
Document and Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Mar-14	'
Entity Registrant Name	'Hill-Rom Holdings, Inc.	'
Entity Central Index Key	'0000047518	'
Current Fiscal Year End Date	'--09-30	'
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	57,220,681

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Income (Loss) (USD $)	3 Months Ended		6 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Net Revenue	'	'	'	'
Capital sales	$313.60	$318.30	$609.10	$642.70
Rental revenue	101.7	107.4	199.6	211.4
Total revenue	415.3	425.7	808.7	854.1
Cost of Revenue	'	'	'	'
Cost of goods sold	169.5	181.7	340.7	370.6
Rental expenses	43.1	47.9	88.5	96
Total cost of revenue	212.6	229.6	429.2	466.6
Gross Profit	202.7	196.1	379.5	387.5
Research and development expenses	16.4	18.3	32.8	35.5
Selling and administrative expenses	130.1	141.4	268.1	278.5
Special charges	28.4	2.9	29.4	2.9
Operating Profit	27.8	33.5	49.2	70.6
Interest expense	-2.3	-2.3	-4.3	-4.6
Investment income and other, net	-0.2	-1.2	-0.2	-0.7
Income Before Income Taxes	25.3	30	44.7	65.3
Income tax expense (Note 9)	28.6	7.7	34.8	19
Net Income (Loss)	($3.30)	$22.30	$9.90	$46.30
Net Income (Loss) per Common Share - Basic	($0.06)	$0.37	$0.17	$0.76
Net Income (Loss) per Common Share - Diluted	($0.06)	$0.37	$0.17	$0.76
Dividends per Common Share	$0.15	$0.13	$0.29	$0.25
Average Common Shares Outstanding - Basic (thousands) (Note 10)	57,303	60,247	57,781	60,565
Average Common Shares Outstanding - Diluted (thousands) (Note 10)	57,303	60,612	58,612	60,818

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (Loss) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Condensed Consolidated Statements of Comprehensive Income (Loss) [Abstract]	'	'	'	'
Net Income (Loss)	($3.30)	$22.30	$9.90	$46.30
Other Comprehensive Income (Loss):	'	'	'	'
Available-for-sale securities and currency hedges, net of tax of $0.0 million and $0.2 million for the quarterly periods, and $0.0 million and $0.2 million for the year to date periods, respectively	0.1	0.2	0.2	0.4
Foreign currency translation adjustment, net of tax of $0.0 million and $0.1 million for the quarterly periods, and $0.0 million and $0.1 million for the year to date periods, respectively	-0.2	-9.8	5.6	-4.3
Change in pension and postretirement defined benefit plans, net of tax of $0.4 million and $0.0 million for the quarterly periods, and $0.8 million and $0.0 million for the year to date periods, respectively	0.5	'	1.1	'
Total Other Comprehensive Income (Loss)	0.4	-9.6	6.9	-3.9
Total Comprehensive Income (Loss)	($2.90)	$12.70	$16.80	$42.40

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Condensed Consolidated Statements of Comprehensive Income (Loss) [Abstract]	'	'	'	'
Available-for-sale securities and currency hedges, tax effect	$0	$0.20	$0	$0.20
Foreign currency translation adjustment, tax effect	0	0.1	0	0.1
Items not yet recognized as a component of net periodic pension and postretirement healthcare costs, tax effect	$0.40	$0	$0.80	$0

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Sep. 30, 2013
In Millions, unless otherwise specified
Current Assets	'	'
Cash and cash equivalents	$120.30	$127.40
Trade accounts receivable, net of allowances (Note 2)	346	361.8
Inventories (Note 2)	120	118.3
Deferred income taxes (Notes 1 and 9)	42.5	48.2
Other current assets	32.5	32.3
Total current assets	661.3	688
Property, plant and equipment, net (Note 2)	222.4	234.3
Goodwill (Notes 3 and 4)	351.6	342.8
Software and other intangible assets, net (Note 2)	237.8	252.7
Deferred income taxes (Notes 1 and 9)	19.3	37.5
Other assets	27.9	31.5
Total Assets	1,520.30	1,586.80
Current Liabilities	'	'
Trade accounts payable	66.5	80.8
Short-term borrowings (Note 5)	124.7	81.2
Accrued compensation	68.7	92.4
Accrued product warranties (Note 12)	34.1	38.1
Other current liabilities	64.1	52.9
Total current liabilities	358.1	345.4
Long-term debt (Note 5)	218.6	225.8
Accrued pension and postretirement benefits (Note 6)	55.8	52.6
Deferred income taxes (Notes 1 and 9)	51.7	67
Other long-term liabilities	31.8	37.3
Total Liabilities	716	728.1
Commitments and Contingencies (Note 14)	'	'
SHAREHOLDERS' EQUITY	'	'
Common Stock (Note 2)	4.4	4.4
Additional paid-in-capital	126.9	122.7
Retained earnings	1,466.80	1,473.80
Accumulated other comprehensive loss (Note 7)	-28.8	-35.7
Treasury stock, at cost (Note 2)	-765	-706.5
Total Shareholders' Equity	804.3	858.7
Total Liabilities and Shareholders' Equity	$1,520.30	$1,586.80

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (USD $)	6 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Operating Activities	'	'
Net income	$9.90	$46.30
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation	33.6	36.9
Amortization	7	9.4
Acquisition-related intangible asset amortization	13.8	13.9
Provision for deferred income taxes	6.5	-9.4
Loss on disposal of property, equipment leased to others, intangible assets and impairments	7.8	0.3
Stock compensation	9	7.6
Excess tax benefits from employee stock plans	0.6	-0.3
Change in working capital excluding cash, current investments, current debt, acquisitions and dispositions:	'	'
Trade accounts receivable	15.8	33.3
Inventories	0.9	-3.8
Other current assets	-1.3	-7.8
Trade accounts payable	-14.5	-6.5
Accrued expenses and other liabilities	-14.6	-3.1
Other, net	3.4	-4.1
Net cash provided by operating activities	77.9	112.7
Investing Activities	'	'
Capital expenditures and purchases of intangible assets	-31.4	-34.4
Proceeds on sales of property and equipment leased to others	1.3	4.8
Payment for acquisition of businesses, net of cash acquired	-9.7	-0.2
Net cash used in investing activities	-39.8	-29.8
Financing Activities	'	'
Net change in short-term debt	-0.2	'
Borrowings (payments) on revolving credit facility	41	-20
Proceeds from long-term debt	0.6	'
Payment of long-term debt	-5	-5.3
Purchase of noncontrolling interest	-1	-1
Payment of cash dividends	-16.7	-15
Proceeds on exercise of options	7.4	5
Proceeds from stock issuance	1.3	1.3
Excess tax benefits from employee stock plans	-0.6	0.3
Treasury stock acquired	-71.6	-44
Net cash used in financing activities	-44.8	-78.7
Effect of exchange rate changes on cash	-0.4	-1.2
Net Cash Flows	-7.1	3
Cash and Cash Equivalents:	'	'
At beginning of period	127.4	84.3
At end of period	$120.30	$87.30

Summary_of_Significant_Account

Summary of Significant Accounting Policies	6 Months Ended
	Mar. 31, 2014
Summary of Significant Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	1.  Summary of Significant Accounting Policies
	Basis of Presentation and Principles of Consolidation
	Unless the context otherwise requires, the terms "Hill-Rom," "we," "our" and "us" refer to Hill-Rom Holdings, Inc. and our wholly-owned subsidiaries.  The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in our latest Annual Report on Form 10-K for the fiscal year ended September 30, 2013 ("2013 Form 10-K") as filed with the United States ("U.S.") Securities and Exchange Commission.  The September 30, 2013 Condensed Consolidated Balance Sheet was derived from audited Consolidated Financial Statements, but does not include all disclosures required by accounting principles generally accepted in the U.S and certain prior year amounts have been reclassified to conform to current year presentation.  In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position, results of operations and cash flows for the interim periods presented.  Quarterly results are not necessarily indicative of annual results.
	The Condensed Consolidated Financial Statements include the accounts of Hill-Rom and its wholly-owned subsidiaries.  Intercompany accounts and transactions have been eliminated in consolidation.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the period.  Actual results could differ from those estimates.  Examples of such estimates include our accounts receivable reserves (Note 2), accrued warranties (Note 12), income taxes (Note 9) and commitments and contingencies (Note 14), among others.
	Fair Value Measurements
	Fair value measurements are classified and disclosed in one of the following three categories:
		·	Level 1:  Financial instruments with unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities.
		·	Level 2:  Financial instruments with observable inputs other than those included in Level 1 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
		·	Level 3:  Financial instruments with unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.  Unobservable inputs reflect our own assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).  Unobservable inputs shall be developed based on the best information available in the circumstances, which might include our own data.
	We record cash and cash equivalents, as disclosed on our Condensed Consolidated Balance Sheets, as Level 1 instruments and certain other insignificant derivatives and investments as either Level 2 or 3 instruments.  Refer to Note 5 for disclosure of our debt instrument fair values.
	Taxes Collected from Customers and Remitted to Governmental Units
	Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes and value added taxes, are accounted for on a net (excluded from revenue and costs) basis.
	Income Taxes
	We and our eligible domestic subsidiaries file a consolidated U.S. income tax return. Foreign operations file income tax returns in a number of jurisdictions.  Deferred income taxes are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. We have a variety of deferred tax assets in numerous tax jurisdictions. These deferred tax assets are subject to periodic assessment as to recoverability.  If it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered.
	As of March 31, 2014, we had $28.5 million of valuation allowances on deferred tax assets, on a tax-effected basis, primarily related to foreign operating loss carryforwards and other tax attributes.  The valuation allowance was increased in the current period by $19.6 million in recognition of a full valuation allowance on the net deferred tax assets in France.  The need for the valuation allowance was determined to be necessary as a result of cumulative and anticipated future losses, due primarily to additional expenses in France associated with restructuring initiatives that commenced in the quarter.  We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances.
	We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit.
	Employee Benefits Change
	During the second quarter of fiscal 2014, we implemented a new paid time off policy as part of our employee benefits programs, replacing certain previously existing vacation and sick time policies.  In conjunction with these changes in policies, the vesting provisions with respect to the accumulation of paid time off were delayed resulting in the recognition and utilization of paid time off in the same benefits year.  As a result of this change, significant portions of our existing accrued vacation balance were no longer necessary and we reversed $12.2 million in the quarter to reflect the change in vesting provisions.  We expect an additional benefit of approximately $2 million in the third quarter of fiscal 2014 as this policy change becomes fully implemented.
	Recently Issued Accounting Standards
	There have been no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1 of Notes to Consolidated Financial Statements in our 2013 Form 10-K except as noted below:
	In February 2013, an accounting standards update was issued that amends the reporting of amounts reclassified out of accumulated other comprehensive income. This standard does not change the current requirements for reporting net income or other comprehensive income ("OCI") in the financial statements. However, the guidance requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component, either on the face of the financial statement where net income is presented or in the notes to the financial statements. The standard is effective for fiscal 2014.  See Note 7 for disclosure of our reclassifications out of accumulated other comprehensive loss ("AOCL").

Supplementary_Balance_Sheet_In

Supplementary Balance Sheet Information	6 Months Ended
	Mar. 31, 2014
Supplementary Balance Sheet Information [Abstract]	'
Supplementary Balance Sheet Information	'
	2.  Supplementary Balance Sheet Information
		31-Mar-14		30-Sep-13
	Allowance for possible losses and discounts on trade receivables	$	27.9	$	30.1
	Inventories:
	Finished products	$	68.5	$	66.3
	Raw materials and work in process		51.5		52
	Total inventory	$	120	$	118.3
	Accumulated depreciation of property, plant and equipment	$	604.2	$	587.4
	Accumulated amortization of software and other intangible assets	$	267.8	$	248.3
	Preferred stock, without par value:
	Shares authorized		1,000,000		1,000,000
	Shares issued	None		None
	Common stock, without par value:
	Shares authorized		199,000,000		199,000,000
	Shares issued		80,323,912		80,323,912
	Shares outstanding		57,219,965		58,523,392
	Treasury shares		23,103,947		21,800,520

Acquisitions

Acquisitions	6 Months Ended
	Mar. 31, 2014
Acquisitions [Abstract]	'
Acquisitions	'
	3.  Acquisitions
	Virtus, Inc.
	On March 31, 2014 we completed a stock purchase agreement with the stockholders of Virtus, Inc. ("Virtus") to acquire the entire equity interest in Virtus; a supplier of finished surfaces and components for our bed and stretcher product lines. The acquisition of Virtus insources a significant component of our supply chain.
	The purchase price was $17.6 million ($13.0 million net of cash acquired).  We funded the transaction primarily with borrowings under the revolving credit facility.  The account balances are included in the Condensed Consolidated Balance Sheets as of the date of acquisition.
	The following summarizes the fair value of assets acquired and liabilities assumed at the date of the acquisition.  These results are preliminary and subject to normal true-up provisions in the stock purchase agreement and other fair value adjustments.
		Amount
	Inventory	$	2.6
	Other current assets		5.4
	Property, plant, and equipment		1.9
	Goodwill		9.6
	Current liabilities		(1.7	)
	Deferred tax liability		(0.2	)
	Total purchase price	$	17.6
	Goodwill is not deductible for tax purposes and was allocated to both our North America and International segments.

Goodwill

Goodwill	6 Months Ended
	Mar. 31, 2014
Goodwill [Abstract]	'
Goodwill	'
	4.  Goodwill
	The following summarizes goodwill activity by reportable segment:
		North America			Surgical and		International			Total
					Respiratory Care
	Balances at September 30, 2013:
	Goodwill	$	383		$	279	$	153.6		$	815.6
	Accumulated impairment losses		(358.1	)		-		(114.7	)		(472.8	)
	Goodwill, net at September 30, 2013		24.9			279		38.9			342.8
	Changes in Goodwill during the period:
	Goodwill related to acquisitions		7.7			-		(1.6	)		6.1
	Currency translation effect		-			2		0.7			2.7
	Balances at March 31, 2014:
	Goodwill		390.7			281		152.7			824.4
	Accumulated impairment losses		(358.1	)		-		(114.7	)		(472.8	)
	Goodwill, net at March 31, 2014	$	32.6		$	281	$	38		$	351.6
	As described in Note 3, we acquired Virtus on March 31, 2014 and recorded goodwill of $9.6 million.  The goodwill was allocated between our North America and International segments based on the expected benefits resulting from the acquisition.
	During the first quarter of fiscal 2014, we entered a settlement agreement relating to certain contractual provisions of the Völker purchase agreement.  This settlement reduced the purchase price by $3.5 million, which was recorded as a reduction of goodwill to our International segment.  The purchase price with respect to Völker is now final.

Financing_Agreements

Financing Agreements	6 Months Ended
	Mar. 31, 2014
Financing Agreements [Abstract]	'
Financing Agreements	'
	5.  Financing Agreements
	Total debt consists of the following:
		31-Mar-14		30-Sep-13
	Revolving credit facility	$	111	$	70
	Term loan, current portion		13.7		11.2
	Term loan, long-term portion		168.8		176.2
	Unsecured 7.00% debentures due on February 15, 2024		19.5		19.6
	Unsecured 6.75% debentures due on December 15, 2027		29.8		29.8
	Other		0.5		0.2
	Total debt		343.3		307
	Less current portion of debt		124.7		81.2
	Total long-term debt	$	218.6	$	225.8
	We have a credit facility that provides for revolving loans of up to $500.0 million, plus term loans in the aggregate amount of $200.0 million.  The Company may request to increase the revolving loan commitment and the amount of the term loans by up to an additional $250.0 million.  All amounts due under the credit facility mature upon expiration on August 24, 2017.  The related term loans amortize so that 37.5 percent of the principal will be repaid over the five year term, with the balance due at maturity.  Borrowings under the credit facility and term loan bear interest at variable rates specified therein, that are currently less than 2.0 percent, and the availability of borrowings is subject to our ability at the time of borrowing to meet certain specified conditions, including compliance with covenants contained in the credit agreement governing the facility.  The credit facility contains covenants that, among other matters, require us to maintain a ratio of consolidated indebtedness to consolidated EBITDA (each as defined in the credit agreement) of not more than 3.5:1.0 and a ratio of consolidated EBITDA to interest expense of not less than 3.5:1.0.  As of March 31, 2014, we had outstanding borrowings of $111.0 million and undrawn letters of credit of $5.2 million under the revolving loan facility, leaving $383.8 million of borrowing capacity available.  We are in compliance with all of our debt covenants as of March 31, 2014.
	Unsecured debentures outstanding at March 31, 2014 have fixed rates of interest.  We have deferred gains included in the amounts above from the termination of previous interest rate swap agreements, and those deferred gains amounted to less than $1.0 million at both March 31, 2014 and September 30, 2013.  The deferred gains are being amortized and recognized as a reduction of interest expense over the remaining term of the related debt through 2024, and as a result, the effective interest rates on that debt have been and will continue to be lower than the stated interest rates.
	We also have trade finance credit lines and uncommitted letter of credit facilities.  These lines are associated with the normal course of business and are not currently, nor have they historically been, of material size to the overall business.
	We are exposed to market risk from fluctuations in interest rates.  The Company sometimes manages its exposure to interest rate fluctuations through the use of interest rate swaps (cash flow hedges).  As of March 31, 2014, we had one interest rate swap agreement with a notional amount of $132.5 million to hedge the variability of cash flows associated with a portion of the term loan variable interest rate payments for the period from January 2014 to August 2017.  The interest rate swap has been designated as a cash flow hedge.  The fair value as of March 31, 2014 and September 30, 2013 was less than $0.1 million.  The fair value measurement for our interest rate swap is classified as Level 2, as described in Note 1.
	The fair value of our debt is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt of the same remaining maturities. The book values of our short-term debt instruments approximate fair value.  The estimated fair values of our long-term unsecured debentures were $54.4 million at March 31, 2014 and $52.5 million at September 30, 2013, and were based on observable inputs such as quoted prices in markets that are not active.  The estimated fair value of our term loan was $181.2 million and $185.5 million based on quoted prices for similar liabilities at March 31, 2014 and September 30, 2013.  The fair value measurements for both our long-term unsecured debentures and our term loan were classified as Level 2, as described in Note 1.

Retirement_and_Postretirement_

Retirement and Postretirement Plans	6 Months Ended
	Mar. 31, 2014
Retirement and Postretirement Plans [Abstract]	'
Retirement and Postretirement Plans	'
	6.  Retirement and Postretirement Plans
	We sponsor four defined benefit retirement plans: a master defined benefit retirement plan, a nonqualified supplemental executive defined benefit retirement plan and two defined benefit retirement plans covering employees in Germany and France.  Benefits for such plans are based primarily on years of service and the employee's level of compensation during specific periods of employment.  We contribute funds to trusts as necessary to provide for current service and for any unfunded projected future benefit obligation over a reasonable period of time for our funded plans.  All of our plans have an annual measurement date of September 30.  The following table includes the components of net pension expense for our defined benefit plans.
		Quarterly Period Ended March 31						Year to Date Period Ended March 31
		2014			2013			2014			2013
	Service cost	$	1.3		$	1.5		$	2.5		$	3
	Interest cost		3.6			3.3			7.2			6.6
	Expected return on plan assets		(4.2	)		(4.0	)		(8.4	)		(8.0	)
	Amortization of unrecognized prior service cost, net		0.1			0.2			0.3			0.3
	Amortization of net loss		0.8			1.9			1.6			3.9
	Net periodic beneift cost		1.6			2.9			3.2			5.8
	Special termination benefits		2.4			-			2.4			-
	Net pension expense	$	4		$	2.9		$	5.6		$	5.8
	We also sponsor a domestic postretirement health care plan that provides health care benefits to qualified retirees and dependents until eligible for Medicare.  Annual costs related to the domestic postretirement health care plan are not significant.
	During the second quarter of fiscal 2014, we initiated a domestic early retirement program, which offered certain special termination benefits relating to our pension and postretirement health care plans.  This program and the related special termination benefits resulted in a non-cash charge of $4.5 million, $2.4 million of which related to our master defined benefit retirement plan and $2.1 million for our postretirement health care plan.  Refer to Note 8 for more details.
	We have defined contribution savings plans that cover substantially all U.S. employees and certain non-U.S. employees.  The general purpose of these plans is to provide additional financial security during retirement by providing employees with an incentive to make regular savings.  Company contributions to the plans are based on eligibility and employee contributions.  Expense under these plans was $3.6 million and $3.3 million in each of the quarterly periods ended March 31, 2014 and 2013; and $7.3 million and $7.0 million in the year to date periods ended March 31, 2014 and 2013.

Other_Comprehensive_Income

Other Comprehensive Income	6 Months Ended
	Mar. 31, 2014
Other Comprehensive Income [Abstract]	'
Other Comprehensive Income	'
	7.  Other Comprehensive Income
	The following table represents the changes in AOCL by component for the year to date period ended March 31, 2014:
		Available-For-Sale			Foreign Currency			Changes in Pension
		Securities and Cash			Translation			and Postretirement
		Flow Hedges (1)			Adjustment (1)			Defined Benefit
								Plans (1)
	Balance as of September 30, 2013	$	(0.3	)	$	(4.6	)	$	(30.8	)
	OCI before reclassifications (2)		0.1			5.6			0.1
	Amounts reclassified out of AOCL		0.1			-			1
	Net current period OCI		0.2			5.6			1.1
	Balance as of March 31, 2014	$	(0.1	)	$	1		$	(29.7	)
	(1)  All amounts are net of tax.
	(2) Net of tax of $0.0, $0.0, and ($0.1) for available-for-sale securities and cash flow hedges, foreign currency translation adjustment, and changes in pension and postretirement defined benefit plans, respectively.
	The following table represents the items reclassified out of AOCL and the related tax effects during fiscal 2014:
		Quarterly Period Ended			Year to Date Period
		31-Mar-14			Ended March 31, 2014
	Pension and postretirement defined benefit plan items
	Amortization of amounts included in net periodic pension expense	$	0.9		$	1.7
	and postretirement healthcare costs (1)
	Tax expense		0.4			0.7
	Net of tax	$	0.5		$	1
	Available-for-sale securities and cash flow hedges items:
	Recognition of other-than-temporary impairment on investment	$	0.1		$	0.1
	securities (2)
	Tax expense		-			-
	Net of tax	$	0.1		$	0.1
	(1) Reclassified from AOCL into cost of goods sold and selling and administrative expenses. These components are included in the computation of net periodic pension expense and postretirement healthcare costs.
	(2) Reclassified from AOCL into other income (expense), net.

Special_Charges

Special Charges	6 Months Ended
	Mar. 31, 2014
Special Charges [Abstract]	'
Special Charges	'
	8.  Special Charges
	We recognized $28.4 million and $2.9 million of special charges for the quarterly periods ended March 31, 2014 and 2013; and $29.4 million and $2.9 million for the year to date periods ended March 31, 2014 and 2013.  These special charges are associated with various organizational restructuring and process transformation programs, as described below.
	We previously announced a global restructuring program to improve our cost structure in January 2014.  As part of this program, we offered an early retirement program to certain U.S. employees.  Through this program, other reduction in force actions, and the elimination of certain contractor and open positions, we will eliminate over 200 net positions primarily in the U.S.  This portion of the program resulted in a special charge of $9.7 million related to severance and other benefits to be provided to affected employees.  We also recorded a $4.5 million charge related to special pension and postretirement healthcare plan benefits granted to employees eligible for the early retirement program.  This portion of the restructuring program is substantially complete, but cash expenditures will continue into fiscal year 2015.  The global restructuring program is reducing our European manufacturing capacity and streamlining our global operations by, among other things, executing a back office process transformation program in Europe.  The restructuring in Europe is in process and resulted in severance and benefit charges of $1.8 million and other costs of $0.9 million related to legal and professional fees, temporary labor, project management, and other administrative functions.  We expect to incur $25 million to $30 million of additional European restructuring costs over the next two years.
	During March 2014, we initiated a plan to discontinue third-party payer rentals of therapy products occurring primarily in home care settings.  We intend to continue renting these products to facilities and customers who are billed directly for the product.  Due to this action, we recorded a non-cash impairment charge of $7.7 million for certain tangible assets for which the carrying values could not be fully recovered as a result of this strategic decision.  We also eliminated approximately 70 positions and recognized a special charge of $2.0 million related to severance and other benefits for affected employees and $1.8 million in other related costs.  We expect the exit of this business to be substantially complete by the end of fiscal 2014, but certain cash expenditures will extend into fiscal 2015.
	During the first quarter of fiscal 2014, we initiated a plan to improve our cost structure and streamline our organization by offering an early retirement program to certain manufacturing employees in our Batesville, Indiana plant, meeting specific eligibility requirements, and other minor reduction in force actions.  These programs resulted in the elimination of approximately 35 positions and required recognition of a special charge of approximately $1 million for lump sum payments under the program and severance and other benefits provided to other affected employees.  This action was substantially complete by the end of the second quarter of fiscal 2014.
	During the second quarter of fiscal 2013, we announced a plan to improve our cost structure and streamline our organization by eliminating approximately 100 positions across the Company, including approximately 50 contract and open positions.  This resulted in a special charge of $1.7 million related to severance and other benefits to be provided to affected employees.  We also incurred a contract termination charge of $0.6 million, a non-cash asset impairment charge of $0.2 million related to a product discontinuance action and $1.0 million in other related costs.  We also reversed $0.6 million of a fiscal 2012 charge that was determined to be excessive during the second quarter of fiscal 2013.  These actions are substantially complete.
	For all accrued severance and other benefit charges described above, we record restructuring reserves within other current liabilities. The reserve activity for severance and other benefits during fiscal 2014 was as follows:
		Balance									Balance
		30-Sep-13		Expenses		Cash Payments			Reversals		31-Mar-14
	Fiscal 2014 Actions:	$	-	$	14.6	$	(1.0	)	$	-	$	13.6
	Prior Restructuring Actions		2.9		-		(1.5	)				1.4
		$	2.9	$	14.6	$	(2.5	)	$	-	$	15

Income_Taxes

Income Taxes	6 Months Ended
	Mar. 31, 2014
Income Taxes [Abstract]	'
Income Taxes	'
	9.  Income Taxes
	The effective tax rate for the quarterly and year to date periods ended March 31, 2014 was 113.0 percent and 77.9 percent, compared to 25.7 percent and 29.1 percent for the comparable periods in the prior year.
	The effective tax rates for both the current period and the first six months of fiscal 2014 are higher than the comparable period in fiscal 2013 due primarily to the tax expense in the current period to establish the valuation allowance in France of $19.6 million as previously discussed in Note 1.  This compares to $2.0 million of period tax benefits in the first six months of fiscal 2013 primarily related to the retroactive reinstatement of the research and development tax credit.

Earnings_per_Common_Share

Earnings per Common Share	6 Months Ended
	Mar. 31, 2014
Earnings per Common Share [Abstract]	'
Earnings per Common Share	'
	10.  Earnings per Common Share
	Basic earnings per share is calculated based upon the weighted average number of outstanding common shares for the period, plus the effect of deferred vested shares.  Diluted earnings per share is calculated consistent with the basic earnings per share calculation plus the effect of dilutive unissued common shares related to stock-based employee compensation programs.  For all periods presented, anti-dilutive stock options were excluded from the calculation of diluted earnings per share.  Cumulative treasury stock acquired, less cumulative shares reissued, have been excluded in determining the average number of shares outstanding.
	Earnings per share are calculated as follows (share information in thousands):
		Quarterly Period Ended March 31					Year to Date Period Ended March 31
		2014			2013		2014		2013
	Net income (loss)	$	(3.3	)	$	22.3	$	9.9	$	46.3
	Average shares outstanding - Basic		57,303			60,247		57,781		60,565
	Add potential effect of exercise of stock options
	and other unvested equity awards		-			365		831		253
	Average shares outstanding - Diluted		57,303			60,612		58,612		60,818
	Net income (loss) per common share - Basic	$	(0.06	)	$	0.37	$	0.17	$	0.76
	Net income (loss) per common share - Diluted	$	(0.06	)	$	0.37	$	0.17	$	0.76
	Shares with anti-dilutive effect excluded from the computation of  Diluted EPS		1,812			1,594		504		1,800

Common_Stock

Common Stock	6 Months Ended
	Mar. 31, 2014
Common Stock [Abstract]	'
Common Stock	'
	11.  Common Stock
	The stock-based compensation cost that was charged against income, net of tax, for all plans was $3.4 million and $5.7 million for the quarterly and year to date periods ended March 31, 2014 and $2.8 million and $4.9 million for the comparable prior year periods.

Guarantees

Guarantees	6 Months Ended
	Mar. 31, 2014
Guarantees [Abstract]	'
Guarantees	'
	12.  Guarantees
	We routinely grant limited warranties on our products with respect to defects in material and workmanship.  The terms of these warranties are generally one year, however, certain components and products have substantially longer warranty periods.  We recognize a reserve with respect to these obligations at the time of product sale, with subsequent warranty claims recorded directly against the reserve.  The amount of the warranty reserve is determined based on historical trend experience for the covered products.  For more significant warranty-related matters which might require a broad-based correction, separate reserves are established when such events are identified and the cost of correction can be reasonably estimated.  The warranty provision for the quarterly and year to date periods ended March 31, 2014 includes net reversals of $1.9 million and $0.7 million as further testing of previously reported issues and actual claims activity supported changes to our prior estimates.  We recorded $5.2 million and $7.7 million of field corrective action charges during the quarterly and year to date periods ended March 31, 2013.  These field corrective actions do not limit the manufacture, sale or ongoing use of these products.
	A reconciliation of changes in the warranty reserve for the periods covered in this report is as follows:
		Quarterly Period Ended March 31						Year to Date Period Ended March 31
		2014			2013			2014			2013
	Balance at beginning of period	$	37.3		$	42		$	38.1		$	42.2
	Provision for warranties during the period		2.6			10.5			7.2			17.1
	Warranty reserves acquired		-			(2.6	)		-			(2.6	)
	Warranty claims during the period		(5.8	)		(8.8	)		(11.2	)		(15.6	)
	Balance at end of period	$	34.1		$	41.1		$	34.1		$	41.1
	In the normal course of business we enter into various other guarantees and indemnities in our relationships with suppliers, service providers, customers, business partners and others.  Examples of these arrangements would include guarantees of product performance, indemnifications to service providers and indemnifications of our actions to business partners.  These guarantees and indemnifications have not historically nor do we expect them to have a material impact on our financial condition or results of operations, although indemnifications associated with our actions generally have no dollar limitations.
	In conjunction with our acquisition and divestiture activities, we have entered into select guarantees and indemnifications of performance with respect to the fulfillment of commitments under applicable purchase and sale agreements.  The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract.  With respect to sale transactions, we also routinely enter into non-competition agreements for varying periods of time.  Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on our financial condition and results of operations.

Segment_Reporting

Segment Reporting	6 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Segment Reporting	'
	13.  Segment Reporting
	We disclose segment information that is consistent with the way in which management operates and views the business. Beginning in fiscal 2014, we changed our definition of divisional income within our internal reporting to management to exclude the impacts of acquisition-related intangible asset amortization.  As a result, we have changed our segment reporting to reflect the way management views the business. The prior year segment information included below has been updated to reflect these changes.
	Our operating structure contains the following reporting segments:
		·	North America - sells and rents our patient care and near-patient technologies and services, as well as our health information technology solutions, in the U.S. and Canada.
		·	Surgical and Respiratory Care - sells and rents our surgical and respiratory care products.
		·	International - sells and rents similar products as our North America segment in regions outside of the U.S. and Canada.
	Our performance under each reportable segment is measured on a divisional income basis before corporate expenses and other non-allocated operating costs, impairment of goodwill and other intangibles, litigation, special charges, and acquisition-related intangible asset amortization.  Divisional income generally represents the division's gross profit less its direct operating costs along with an allocation of manufacturing and distribution costs, research and development and certain corporate functional expenses.
	Corporate expenses and other non-allocated operating costs, while not considered a segment, are presented separately to aid in the reconciliation of segment information to consolidated financial information. Corporate expenses include functional expenses that support the entire organization such as administration, finance, legal and human resources.  Other non-allocated operating costs generally include expenses associated with strategic developments, acquisition-related intangible asset amortization, and other events that are not indicative of operating trends.  We exclude such amounts from divisional income to allow management to evaluate and understand divisional operating trends without the effects of such items.
			Quarterly Period Ended March 31						Year to Date Period Ended March 31
			2014			2013			2014			2013
	Revenue:
	North America		$	224.5		$	239.7		$	430		$	474.4
	Surgical and Respiratory Care			65.6			61.2			128.9			120.2
	International			125.2			124.8			249.8			259.5
	Total revenue		$	415.3		$	425.7		$	808.7		$	854.1
	Divisional income:
	North America		$	47.5		$	54.6		$	75.5		$	100.1
	Surgical and Respiratory Care			15.7			13.5			30.3			27.6
	International			5.2			5.3			10.7			15.4
	Other operating costs:
	Corporate expenses and other non-allocated operating costs			12.2			37			37.9			69.6
	Special charges			28.4			2.9			29.4			2.9
	Operating profit			27.8			33.5			49.2			70.6
	Interest expense			(2.3	)		(2.3	)		(4.3	)		(4.6	)
	Investment income and other, net			(0.2	)		(1.2	)		(0.2	)		(0.7	)
	Income before income taxes		$	25.3		$	30		$	44.7		$	65.3

Commitments_and_Contingencies

Commitments and Contingencies	6 Months Ended
	Mar. 31, 2014
Commitments and Contingencies [Abstract]	'
Commitments and Contingencies	'
	14.  Commitments and Contingencies
	General
	We are subject to various claims and contingencies arising out of the normal course of business, including those relating to governmental investigations and proceedings, commercial transactions, product liability, employee related matters, antitrust, safety, health, taxes, environmental and other matters.  Litigation is subject to many uncertainties and the outcome of individual litigated matters is not predictable with assurance.  It is possible that some litigation matters for which reserves have not been established could be decided unfavorably to us, and that any such unfavorable decisions could have a material adverse effect on our financial condition, results of operations and cash flows.
	We are also involved in other possible claims, including product and general liability, workers' compensation, auto liability and employment related matters. Such claims in the United States have deductibles and self-insured retentions ranging from $25 thousand to $1.0 million per occurrence or per claim, depending upon the type of coverage and policy period. International deductibles and self-insured retentions are lower.  We are also generally self-insured up to certain stop-loss limits for certain employee health benefits, including medical, drug and dental.  Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims and outside actuarial analysis, which are based on historical information along with certain assumptions about future events. Such estimated reserves are classified as Other Current Liabilities and Other Long-Term Liabilities within the Condensed Consolidated Balance Sheets.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Mar. 31, 2014
Summary of Significant Accounting Policies [Abstract]	'
Basis of Presentation and Principles of Consolidation	'
	Basis of Presentation and Principles of Consolidation
	Unless the context otherwise requires, the terms "Hill-Rom," "we," "our" and "us" refer to Hill-Rom Holdings, Inc. and our wholly-owned subsidiaries.  The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in our latest Annual Report on Form 10-K for the fiscal year ended September 30, 2013 ("2013 Form 10-K") as filed with the United States ("U.S.") Securities and Exchange Commission.  The September 30, 2013 Condensed Consolidated Balance Sheet was derived from audited Consolidated Financial Statements, but does not include all disclosures required by accounting principles generally accepted in the U.S and certain prior year amounts have been reclassified to conform to current year presentation.  In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position, results of operations and cash flows for the interim periods presented.  Quarterly results are not necessarily indicative of annual results.
	The Condensed Consolidated Financial Statements include the accounts of Hill-Rom and its wholly-owned subsidiaries.  Intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the period.  Actual results could differ from those estimates.  Examples of such estimates include our accounts receivable reserves (Note 2), accrued warranties (Note 12), income taxes (Note 9) and commitments and contingencies (Note 14), among others.
Fair Value Measurements	'
	Fair Value Measurements
	Fair value measurements are classified and disclosed in one of the following three categories:
		·	Level 1:  Financial instruments with unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities.
		·	Level 2:  Financial instruments with observable inputs other than those included in Level 1 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
		·	Level 3:  Financial instruments with unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.  Unobservable inputs reflect our own assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).  Unobservable inputs shall be developed based on the best information available in the circumstances, which might include our own data.
	We record cash and cash equivalents, as disclosed on our Condensed Consolidated Balance Sheets, as Level 1 instruments and certain other insignificant derivatives and investments as either Level 2 or 3 instruments.  Refer to Note 5 for disclosure of our debt instrument fair values.
Taxes Collected from Customers and Remitted to Governmental Units	'
	Taxes Collected from Customers and Remitted to Governmental Units
	Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes and value added taxes, are accounted for on a net (excluded from revenue and costs) basis.
Income Taxes	'
	Income Taxes
	We and our eligible domestic subsidiaries file a consolidated U.S. income tax return. Foreign operations file income tax returns in a number of jurisdictions.  Deferred income taxes are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. We have a variety of deferred tax assets in numerous tax jurisdictions. These deferred tax assets are subject to periodic assessment as to recoverability.  If it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered.
	As of March 31, 2014, we had $28.5 million of valuation allowances on deferred tax assets, on a tax-effected basis, primarily related to foreign operating loss carryforwards and other tax attributes.  The valuation allowance was increased in the current period by $19.6 million in recognition of a full valuation allowance on the net deferred tax assets in France.  The need for the valuation allowance was determined to be necessary as a result of cumulative and anticipated future losses, due primarily to additional expenses in France associated with restructuring initiatives that commenced in the quarter.  We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances.
	We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit.
Employee Benefits Change	'
	Employee Benefits Change
	During the second quarter of fiscal 2014, we implemented a new paid time off policy as part of our employee benefits programs, replacing certain previously existing vacation and sick time policies.  In conjunction with these changes in policies, the vesting provisions with respect to the accumulation of paid time off were delayed resulting in the recognition and utilization of paid time off in the same benefits year.  As a result of this change, significant portions of our existing accrued vacation balance were no longer necessary and we reversed $12.2 million in the quarter to reflect the change in vesting provisions.  We expect an additional benefit of approximately $2 million in the third quarter of fiscal 2014 as this policy change becomes fully implemented.
Recently Issued Accounting Standards	'
	Recently Issued Accounting Standards
	There have been no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1 of Notes to Consolidated Financial Statements in our 2013 Form 10-K except as noted below:
	In February 2013, an accounting standards update was issued that amends the reporting of amounts reclassified out of accumulated other comprehensive income. This standard does not change the current requirements for reporting net income or other comprehensive income ("OCI") in the financial statements. However, the guidance requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component, either on the face of the financial statement where net income is presented or in the notes to the financial statements. The standard is effective for fiscal 2014.  See Note 7 for disclosure of our reclassifications out of accumulated other comprehensive loss ("AOCL").

Supplementary_Balance_Sheet_In1

Supplementary Balance Sheet Information (Tables)	6 Months Ended
	Mar. 31, 2014
Supplementary Balance Sheet Information [Abstract]	'
Supplementary Balance Sheet Information	'
		31-Mar-14		30-Sep-13
	Allowance for possible losses and discounts on trade receivables	$	27.9	$	30.1
	Inventories:
	Finished products	$	68.5	$	66.3
	Raw materials and work in process		51.5		52
	Total inventory	$	120	$	118.3
	Accumulated depreciation of property, plant and equipment	$	604.2	$	587.4
	Accumulated amortization of software and other intangible assets	$	267.8	$	248.3
	Preferred stock, without par value:
	Shares authorized		1,000,000		1,000,000
	Shares issued	None		None
	Common stock, without par value:
	Shares authorized		199,000,000		199,000,000
	Shares issued		80,323,912		80,323,912
	Shares outstanding		57,219,965		58,523,392
	Treasury shares		23,103,947		21,800,520

Acquisitions_Tables

Acquisitions (Tables)	6 Months Ended
	Mar. 31, 2014
Business Acquisition [Line Items]	'
Schedule of Fair Value of the Assets Acquired and Liabilities Assumed	'
	The following summarizes the fair value of assets acquired and liabilities assumed at the date of the acquisition.  These results are preliminary and subject to normal true-up provisions in the stock purchase agreement and other fair value adjustments.
		Amount
	Inventory	$	2.6
	Other current assets		5.4
	Property, plant, and equipment		1.9
	Goodwill		9.6
	Current liabilities		(1.7	)
	Deferred tax liability		(0.2	)
	Total purchase price	$	17.6

Goodwill_Tables

Goodwill (Tables)	6 Months Ended
	Mar. 31, 2014
Goodwill [Abstract]	'
Schedule of Goodwill Activity	'
	The following summarizes goodwill activity by reportable segment:
		North America			Surgical and		International			Total
					Respiratory Care
	Balances at September 30, 2013:
	Goodwill	$	383		$	279	$	153.6		$	815.6
	Accumulated impairment losses		(358.1	)		-		(114.7	)		(472.8	)
	Goodwill, net at September 30, 2013		24.9			279		38.9			342.8
	Changes in Goodwill during the period:
	Goodwill related to acquisitions		7.7			-		(1.6	)		6.1
	Currency translation effect		-			2		0.7			2.7
	Balances at March 31, 2014:
	Goodwill		390.7			281		152.7			824.4
	Accumulated impairment losses		(358.1	)		-		(114.7	)		(472.8	)
	Goodwill, net at March 31, 2014	$	32.6		$	281	$	38		$	351.6

Financing_Agreements_Tables

Financing Agreements (Tables)	6 Months Ended
	Mar. 31, 2014
Financing Agreements [Abstract]	'
Schedule of Total Debt	'
	Total debt consists of the following:
		31-Mar-14		30-Sep-13
	Revolving credit facility	$	111	$	70
	Term loan, current portion		13.7		11.2
	Term loan, long-term portion		168.8		176.2
	Unsecured 7.00% debentures due on February 15, 2024		19.5		19.6
	Unsecured 6.75% debentures due on December 15, 2027		29.8		29.8
	Other		0.5		0.2
	Total debt		343.3		307
	Less current portion of debt		124.7		81.2
	Total long-term debt	$	218.6	$	225.8

Retirement_and_Postretirement_1

Retirement and Postretirement Plans (Tables)	6 Months Ended
	Mar. 31, 2014
Retirement and Postretirement Plans [Abstract]	'
Components of Net Pension Expense for Defined Benefit Plans	'
	The following table includes the components of net pension expense for our defined benefit plans.
		Quarterly Period Ended March 31						Year to Date Period Ended March 31
		2014			2013			2014			2013
	Service cost	$	1.3		$	1.5		$	2.5		$	3
	Interest cost		3.6			3.3			7.2			6.6
	Expected return on plan assets		(4.2	)		(4.0	)		(8.4	)		(8.0	)
	Amortization of unrecognized prior service cost, net		0.1			0.2			0.3			0.3
	Amortization of net loss		0.8			1.9			1.6			3.9
	Net periodic beneift cost		1.6			2.9			3.2			5.8
	Special termination benefits		2.4			-			2.4			-
	Net pension expense	$	4		$	2.9		$	5.6		$	5.8

Other_Comprehensive_Income_Tab

Other Comprehensive Income (Tables)	6 Months Ended
	Mar. 31, 2014
Other Comprehensive Income [Abstract]	'
Schedule of Changes in AOCL by Component	'
	The following table represents the changes in AOCL by component for the year to date period ended March 31, 2014:
		Available-For-Sale			Foreign Currency			Changes in Pension
		Securities and Cash			Translation			and Postretirement
		Flow Hedges (1)			Adjustment (1)			Defined Benefit
								Plans (1)
	Balance as of September 30, 2013	$	(0.3	)	$	(4.6	)	$	(30.8	)
	OCI before reclassifications (2)		0.1			5.6			0.1
	Amounts reclassified out of AOCL		0.1			-			1
	Net current period OCI		0.2			5.6			1.1
	Balance as of March 31, 2014	$	(0.1	)	$	1		$	(29.7	)
	(1)  All amounts are net of tax.
	(2) Net of tax of $0.0, $0.0, and ($0.1) for available-for-sale securities and cash flow hedges, foreign currency translation adjustment, and changes in pension and postretirement defined benefit plans, respectively.
Schedule of Items Reclassified out of AOCL	'
	The following table represents the items reclassified out of AOCL and the related tax effects during fiscal 2014:
		Quarterly Period Ended			Year to Date Period
		31-Mar-14			Ended March 31, 2014
	Pension and postretirement defined benefit plan items
	Amortization of amounts included in net periodic pension expense	$	0.9		$	1.7
	and postretirement healthcare costs (1)
	Tax expense		0.4			0.7
	Net of tax	$	0.5		$	1
	Available-for-sale securities and cash flow hedges items:
	Recognition of other-than-temporary impairment on investment	$	0.1		$	0.1
	securities (2)
	Tax expense		-			-
	Net of tax	$	0.1		$	0.1
	(1) Reclassified from AOCL into cost of goods sold and selling and administrative expenses. These components are included in the computation of net periodic pension expense and postretirement healthcare costs.
	(2) Reclassified from AOCL into other income (expense), net.

Special_Charges_Tables

Special Charges (Tables)	6 Months Ended
	Mar. 31, 2014
Special Charges [Abstract]	'
Restructuring Activity	'
	For all accrued severance and other benefit charges described above, we record restructuring reserves within other current liabilities. The reserve activity for severance and other benefits during fiscal 2014 was as follows:
		Balance									Balance
		30-Sep-13		Expenses		Cash Payments			Reversals		31-Mar-14
	Fiscal 2014 Actions:	$	-	$	14.6	$	(1.0	)	$	-	$	13.6
	Prior Restructuring Actions		2.9		-		(1.5	)				1.4
		$	2.9	$	14.6	$	(2.5	)	$	-	$	15

Earnings_per_Common_Share_Tabl

Earnings per Common Share (Tables)	6 Months Ended
	Mar. 31, 2014
Earnings per Common Share [Abstract]	'
Calculated Earnings per Share	'
	Earnings per share are calculated as follows (share information in thousands):
		Quarterly Period Ended March 31					Year to Date Period Ended March 31
		2014			2013		2014		2013
	Net income (loss)	$	(3.3	)	$	22.3	$	9.9	$	46.3
	Average shares outstanding - Basic		57,303			60,247		57,781		60,565
	Add potential effect of exercise of stock options
	and other unvested equity awards		-			365		831		253
	Average shares outstanding - Diluted		57,303			60,612		58,612		60,818
	Net income (loss) per common share - Basic	$	(0.06	)	$	0.37	$	0.17	$	0.76
	Net income (loss) per common share - Diluted	$	(0.06	)	$	0.37	$	0.17	$	0.76
	Shares with anti-dilutive effect excluded from the computation of  Diluted EPS		1,812			1,594		504		1,800

Guarantees_Tables

Guarantees (Tables)	6 Months Ended
	Mar. 31, 2014
Guarantees [Abstract]	'
Reconciliation of Changes in the Warranty Reserve	'
	A reconciliation of changes in the warranty reserve for the periods covered in this report is as follows:
		Quarterly Period Ended March 31						Year to Date Period Ended March 31
		2014			2013			2014			2013
	Balance at beginning of period	$	37.3		$	42		$	38.1		$	42.2
	Provision for warranties during the period		2.6			10.5			7.2			17.1
	Warranty reserves acquired		-			(2.6	)		-			(2.6	)
	Warranty claims during the period		(5.8	)		(8.8	)		(11.2	)		(15.6	)
	Balance at end of period	$	34.1		$	41.1		$	34.1		$	41.1

Segment_Reporting_Tables

Segment Reporting (Tables)	6 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Reconciliation of Segment Information to Consolidated Financial Information	'
		Quarterly Period Ended March 31						Year to Date Period Ended March 31
		2014			2013			2014			2013
	Revenue:
	North America	$	224.5		$	239.7		$	430		$	474.4
	Surgical and Respiratory Care		65.6			61.2			128.9			120.2
	International		125.2			124.8			249.8			259.5
	Total revenue	$	415.3		$	425.7		$	808.7		$	854.1
	Divisional income:
	North America	$	47.5		$	54.6		$	75.5		$	100.1
	Surgical and Respiratory Care		15.7			13.5			30.3			27.6
	International		5.2			5.3			10.7			15.4
	Other operating costs:
	Corporate expenses and other non-allocated operating costs		12.2			37			37.9			69.6
	Special charges		28.4			2.9			29.4			2.9
	Operating profit		27.8			33.5			49.2			70.6
	Interest expense		(2.3	)		(2.3	)		(4.3	)		(4.6	)
	Investment income and other, net		(0.2	)		(1.2	)		(0.2	)		(0.7	)
	Income before income taxes	$	25.3		$	30		$	44.7		$	65.3

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details) (USD $)	6 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2014	Jun. 30, 2014
		Paid Time Off Policy [Member]	Paid Time Off Policy [Member]
			Scenario, Forecast [Member]
Summary of Significant Accounting Policies [Abstract]	'	'	'
Valuation allowance on deferred tax assets	$28.50	'	'
Net change in valuation allowance	19.6	'	'
Employee Benefits Change	'	'	'
Employee benefits expense reversed	'	($12.20)	($2)

Supplementary_Balance_Sheet_In2

Supplementary Balance Sheet Information (Details) (USD $)	Mar. 31, 2014	Sep. 30, 2013
In Millions, except Share data, unless otherwise specified
Supplementary Balance Sheet Information [Abstract]	'	'
Allowance for possible losses and discounts on trade receivables	$27.90	$30.10
Inventories:	'	'
Finished products	68.5	66.3
Raw materials and work in process	51.5	52
Total inventory	120	118.3
Accumulated depreciation of property, plant and equipment	604.2	587.4
Accumulated amortization of software and other intangible assets	$267.80	$248.30
Preferred stock, without par value:	'	'
Par value	'	'
Shares authorized	1,000,000	1,000,000
Shares issued	0	0
Common stock, without par value:	'	'
Par value	'	'
Shares authorized	199,000,000	199,000,000
Shares issued	80,323,912	80,323,912
Shares outstanding	57,219,965	58,523,392
Treasury shares	23,103,947	21,800,520

Acquisitions_Details

Acquisitions (Details) (USD $)	6 Months Ended			0 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Sep. 30, 2013	Mar. 31, 2014
				Virtus, Inc. [Member]
Business Acquisition [Line Items]	'	'	'	'
Purchase price of entity	'	'	'	$17.60
Purchase price of entity, net of cash acquired	9.7	0.2	'	13
Fair value of the assets acquired and liabilities assumed:	'	'	'	'
Inventory	'	'	'	2.6
Other current assets	'	'	'	5.4
Property, plant, and equipment	'	'	'	1.9
Goodwill	351.6	'	342.8	9.6
Current liabilities	'	'	'	-1.7
Deferred tax liability	'	'	'	-0.2
Total purchase price	'	'	'	$17.60

Goodwill_Details

Goodwill (Details) (USD $)	6 Months Ended		3 Months Ended	6 Months Ended		6 Months Ended		3 Months Ended	6 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Sep. 30, 2013	Mar. 31, 2014	Mar. 31, 2014	Sep. 30, 2013	Mar. 31, 2014	Sep. 30, 2013	Dec. 31, 2013	Mar. 31, 2014	Sep. 30, 2013
			Virtus, Inc. [Member]	North America Segment [Member]	North America Segment [Member]	Surgical and Respiratory Care Segment [Member]	Surgical and Respiratory Care Segment [Member]	International [Member]	International [Member]	International [Member]
Goodwill [Roll Forward]	'	'	'	'	'	'	'	'	'	'
Goodwill	$824.40	$815.60	'	$390.70	$383	$281	$279	'	$152.70	$153.60
Accumulated impairment losses	-472.8	-472.8	'	-358.1	-358.1	'	'	'	-114.7	-114.7
Goodwill, net	351.6	342.8	9.6	32.6	24.9	281	279	'	38	38.9
Goodwill related to acquisitions	6.1	'	9.6	7.7	'	'	'	-3.5	-1.6	'
Currency translation effect	$2.70	'	'	'	'	$2	'	'	$0.70	'

Financing_Agreements_Schedule_

Financing Agreements (Schedule of Total Debt) (Details) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Sep. 30, 2013
Long-term Debt, by Current and Noncurrent [Abstract]	'	'
Total debt	$343.30	$307
Less current portion of debt	124.7	81.2
Total long-term debt	218.6	225.8
Revolving Credit Facility [Member]	'	'
Long-term Debt, by Current and Noncurrent [Abstract]	'	'
Total debt	111	70
Term Loan [Member]	'	'
Long-term Debt, by Current and Noncurrent [Abstract]	'	'
Less current portion of debt	13.7	11.2
Total long-term debt	168.8	176.2
Unsecured 7.00% Debentures due on February 15, 2024 [Member]	'	'
Long-term Debt, by Current and Noncurrent [Abstract]	'	'
Total debt	19.5	19.6
Unsecured debenture interest rate	7.00%	'
Debt instrument, maturity date	15-Feb-24	'
Unsecured 6.75% Debentures due on December 15, 2027 [Member]	'	'
Long-term Debt, by Current and Noncurrent [Abstract]	'	'
Total debt	29.8	29.8
Unsecured debenture interest rate	6.75%	'
Debt instrument, maturity date	15-Dec-27	'
Other [Member]	'	'
Long-term Debt, by Current and Noncurrent [Abstract]	'	'
Total debt	$0.50	$0.20

Financing_Agreements_Narrative

Financing Agreements (Narrative) (Details) (USD $)	Mar. 31, 2014	Sep. 30, 2013	Mar. 31, 2014	Sep. 30, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014
In Millions, unless otherwise specified			Interest Rate Swap [Member]	Interest Rate Swap [Member]	New Credit Facility [Member]	Term Loan [Member]	Potential Increase to Credit Facility [Member]	Maximum [Member]	Minimum [Member]
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'	'
Deferred gains from the termination of previous interest rate swap agreements	$1	$1	'	'	'	'	'	'	'
Revolving credit facility, maximum borrowing amount	'	'	'	'	500	'	250	'	'
Term loan principal amount	'	'	'	'	'	200	'	'	'
Credit facility expiration date	'	'	'	'	24-Aug-17	'	'	'	'
Percent of principal to be repaid over term	'	'	'	'	37.50%	'	'	'	'
Number of years under revolving credit facility	'	'	'	'	'5 years	'	'	'	'
Maximum interest rate during period	'	'	'	'	2.00%	'	'	'	'
Ratio of consolidated indebtedness to consolidated EBITDA	'	'	'	'	'	'	'	3.5	'
Interest coverage ratio	'	'	'	'	'	'	'	'	3.5
Outstanding borrowings	'	'	'	'	111	'	'	'	'
Undrawn letters of credit	'	'	'	'	5.2	'	'	'	'
Current borrowing capacity under the facility	'	'	'	'	383.8	'	'	'	'
Fair value of unsecured debentures	54.4	52.5	'	'	'	'	'	'	'
Fair value of term loan	181.2	185.5	'	'	'	'	'	'	'
Interest rate swap agreement, notional amount	'	'	132.5	'	'	'	'	'	'
Interest rate swap agreement, fair value	'	'	$0.10	$0.10	'	'	'	'	'

Retirement_and_Postretirement_2

Retirement and Postretirement Plans (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Special termination benefits	$4.50	'	'	'
Defined contribution savings plans expense	3.6	3.3	7.3	7
Master Defined Benefit Retirement Plan [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Service cost	1.3	1.5	2.5	3
Interest cost	3.6	3.3	7.2	6.6
Expected return on plan assets	-4.2	-4	-8.4	-8
Amortization of unrecognized prior service cost, net	0.1	0.2	0.3	0.3
Amortization of net loss	0.8	1.9	1.6	3.9
Net periodic beneift cost	1.6	2.9	3.2	5.8
Special termination benefits	2.4	'	2.4	'
Net pension expense	4	2.9	5.6	5.8
Postretirement Health Care Plan [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Special termination benefits	$2.10	'	'	'

Other_Comprehensive_Income_Sch

Other Comprehensive Income (Schedule of Changes in AOCL by Component) (Details) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Beginning balance	($35.70)
Ending balance	-28.8
Tax effect of available-for-sale securities and cash flow hedges, before reclassification	0
Tax effect of foreign currency translation adjustment, before reclassification	0
Tax effect of items not yet recognized as a component of net periodic pension and postretirement healthcare costs, before reclassification	-0.1
Available-For-Sale Securities and Cash Flow Hedges [Member]	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Beginning balance	-0.3	[1]
OCI before reclassifications	0.1	[1],[2]
Amounts reclassified out of AOCL	0.1	[1]
Net current period OCI	0.2	[1]
Ending balance	-0.1	[1]
Foreign Currency Translation Adjustment [Member]	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Beginning balance	-4.6	[1]
OCI before reclassifications	5.6	[1],[2]
Amounts reclassified out of AOCL	'	[1]
Net current period OCI	5.6	[1]
Ending balance	1	[1]
Pension and Postretirement Defined Denefit Plan Items [Member]	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Beginning balance	-30.8	[1]
OCI before reclassifications	0.1	[1],[2]
Amounts reclassified out of AOCL	1	[1]
Net current period OCI	1.1	[1]
Ending balance	($29.70)	[1]
[1]	All amounts are net of tax.
[2]	Net of tax of $0.0, $0.0, and ($0.1) for available-for-sale securities and cash flow hedges, foreign currency translation adjustment, and changes in pension and postretirement defined benefit plans, respectively.

Other_Comprehensive_Income_Sch1

Other Comprehensive Income (Schedule of Items Reclassified out of AOCL) (Details) (USD $)	3 Months Ended			6 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014		Mar. 31, 2013	Mar. 31, 2014		Mar. 31, 2013
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'		'	'		'
Amount before tax	($25.30)		($30)	($44.70)		($65.30)
Tax expense	-28.6		-7.7	-34.8		-19
Net of tax	3.3		-22.3	-9.9		-46.3
Pension and Postretirement Defined Denefit Plan Items [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'		'	'		'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'		'	'		'
Amount before tax	0.9	[1]	'	1.7	[1]	'
Tax expense	0.4		'	0.7		'
Net of tax	0.5		'	1		'
Available-For-Sale Securities and Cash Flow Hedges Items [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'		'	'		'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'		'	'		'
Amount before tax	0.1	[2]	'	0.1	[2]	'
Tax expense	'		'	'		'
Net of tax	$0.10		'	$0.10		'
[1]	Reclassified from AOCL into cost of goods sold and selling and administrative expenses. These components are included in the computation of net periodic pension expense and postretirement healthcare costs.
[2]	Reclassified from AOCL into other income (expense), net.

Special_Charges_Narrative_Deta

Special Charges (Narrative) (Details) (USD $)

3 Months Ended

6 Months Ended

3 Months Ended

In Millions, unless otherwise specified

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Fiscal 2014 Actions [Member]

Global Restructuring Program [Member]

Global Restructuring Program [Member]

Global Restructuring Program [Member]

Global Restructuring Program [Member]

Global Restructuring Program [Member]

Global Restructuring Program [Member]

Global Restructuring Program [Member]

Plan to Discontinue Third Party Payer Rentals [Member]

Plan to Discontinue Third Party Payer Rentals [Member]

Plan to Discontinue Third Party Payer Rentals [Member]

Batesville, Indiana Plant Restructuring [Member]

Fiscal 2013 Action [Member]

Fiscal 2013 Action [Member]

Fiscal 2013 Action [Member]

Fiscal 2013 Action [Member]

Fiscal 2012 Action [Member]

employees

Employee Termination and Severance [Member]

Employee Termination and Severance [Member]

Special Termination Benefits [Member]

Other Restructuring [Member]

Minimum [Member]

Maximum [Member]

employees

Employee Termination and Severance [Member]

Other Restructuring [Member]

employees

employees

Employee Termination and Severance [Member]

Lease and Other Contract Termination [Member]

Other Restructuring [Member]

Europe [Member]

Europe [Member]

Europe [Member]

Europe [Member]

Restructuring Cost and Reserve [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Special charge

$28.40

$2.90

$29.40

$2.90

'

'

$9.70

$1.80

$4.50

$0.90

'

'

'

$2

$1.80

$1

'

$1.70

$0.60

$1

'

Impairment of certain tangible assets

'

'

'

'

'

'

'

'

'

'

'

'

7.7

'

'

'

0.2

'

'

'

'

Number of positions planned to be eliminated

'

'

'

'

'

200

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of positions eliminated

'

'

'

'

'

'

'

'

'

'

'

'

70

'

'

35

100

'

'

'

'

Number of contract and open positions planned to be eliminated

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50

'

'

'

'

Expected additional costs

'

'

'

'

'

'

'

'

'

'

25

30

'

'

'

'

'

'

'

'

'

Reversals

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

($0.60)

Special_Charges_Schedule_of_Re

Special Charges (Schedule of Restructuring Activity) (Details) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014
Restructuring Reserve [Roll Forward]	'
Beginning Balance	$2.90
Expenses	14.6
Cash Payments	-2.5
Reversals	'
Ending Balance	15
Fiscal 2014 Actions [Member]	'
Restructuring Reserve [Roll Forward]	'
Beginning Balance	'
Expenses	14.6
Cash Payments	-1
Reversals	'
Ending Balance	13.6
Prior Restructuring Actions [Member]	'
Restructuring Reserve [Roll Forward]	'
Beginning Balance	2.9
Expenses	'
Cash Payments	-1.5
Reversals	'
Ending Balance	$1.40

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Income Taxes [Abstract]	'	'	'	'
Effective tax rate	113.00%	25.70%	77.90%	29.10%
Effect of valuation allowance establishment on tax expense	$19.60	'	$19.60	'
Favorable impact of period tax benefits	'	'	'	$2

Earnings_per_Common_Share_Deta

Earnings per Common Share (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Earnings per Common Share [Abstract]	'	'	'	'
Net income (loss)	($3.30)	$22.30	$9.90	$46.30
Average shares outstanding - Basic	57,303	60,247	57,781	60,565
Add potential effect of exercise of stock options and other unvested equity awards	'	365	831	253
Average shares outstanding - Diluted	57,303	60,612	58,612	60,818
Net income (loss) per common share - Basic	($0.06)	$0.37	$0.17	$0.76
Net income (loss) per common share - Diluted	($0.06)	$0.37	$0.17	$0.76
Shares with anti-dilutive effect excluded from the computation of Diluted EPS	1,812	1,594	504	1,800

Common_Stock_Details

Common Stock (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Common Stock [Abstract]	'	'	'	'
Stock based compensation cost charged against income, net of tax	$3.40	$2.80	$5.70	$4.90

Guarantees_Details

Guarantees (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Guarantees [Abstract]	'	'	'	'
Charge related to field corrective action	'	$5.20	'	$7.70
Warranty provision, net reversals	-1.9	'	-0.7	'
Movement in Standard Product Warranty Accrual [Roll Forward]	'	'	'	'
Balance at beginning of period	37.3	42	38.1	42.2
Provision for warranties during the period	2.6	10.5	7.2	17.1
Warranty reserves acquired	'	-2.6	'	-2.6
Warranty claims during the period	-5.8	-8.8	-11.2	-15.6
Balance at end of period	$34.10	$41.10	$34.10	$41.10

Segment_Reporting_Details

Segment Reporting (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Segment Reporting Information [Line Items]	'	'	'	'
Revenues	$415.30	$425.70	$808.70	$854.10
Special charge	28.4	2.9	29.4	2.9
Operating profit	27.8	33.5	49.2	70.6
Interest expense	-2.3	-2.3	-4.3	-4.6
Investment income and other, net	-0.2	-1.2	-0.2	-0.7
Income Before Income Taxes	25.3	30	44.7	65.3
Corporate and Other [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Operating profit	-12.2	-37	-37.9	-69.6
Segment Reconciling Items [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Special charge	28.4	2.9	29.4	2.9
North America Segment [Member] | Operating Segments [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Revenues	224.5	239.7	430	474.4
Operating profit	47.5	54.6	75.5	100.1
Surgical and Respiratory Care Segment [Member] | Operating Segments [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Revenues	65.6	61.2	128.9	120.2
Operating profit	15.7	13.5	30.3	27.6
International [Member] | Operating Segments [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Revenues	125.2	124.8	249.8	259.5
Operating profit	$5.20	$5.30	$10.70	$15.40

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (Uninsured Risk [Member], USD $)	Mar. 31, 2014
Uninsured Risk [Member]	'
Loss Contingencies [Line Items]	'
Deductibles and self-insured retentions, minimum	$25,000
Deductibles and self-insured retentions, maximum	$1,000,000